Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

Serum iron in catatonia and neuroleptic malignant syndrome.

Lee JW.

Biol Psychiatry. 1998 Sep 15;44(6):499-507.

PMID:
9777183
2.

Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.

Lee JW.

J Clin Psychopharmacol. 2010 Feb;30(1):3-10. doi: 10.1097/JCP.0b013e3181c9bfe6.

PMID:
20075641
3.
4.

[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].

Askenazy F, Dor E, Benoit M, Dupuis G, Serret S, Myquel M, Seddiki Y.

Encephale. 2010 Feb;36(1):46-53. doi: 10.1016/j.encep.2009.01.006. Epub 2009 May 12. French.

PMID:
20159196
5.

Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.

Lee JW, Robertson S.

Ann Clin Psychiatry. 1997 Sep;9(3):165-9.

PMID:
9339882
6.

Neuroleptic malignant syndrome and catatonia. A report of three cases.

Raja M, Altavista MC, Cavallari S, Lubich L.

Eur Arch Psychiatry Clin Neurosci. 1994;243(6):299-303.

PMID:
7913834
7.

[Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].

Luchini F, Lattanzi L, Bartolommei N, Cosentino L, Casamassima F, Litta A, Mauri M, Cassano GB.

Riv Psichiatr. 2012 Mar-Apr;47(2):178-85. doi: 10.1708/1069.11721. Italian.

PMID:
22622253
8.

Neuroleptic catatonia and its relationship to psychogenic catatonia.

Fricchione GL.

Biol Psychiatry. 1985 Mar;20(3):304-13.

PMID:
2858225
9.

Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.

Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J.

World J Biol Psychiatry. 2009;10(1):70-3. doi: 10.1080/15622970701287369.

PMID:
19673089
10.

[Acute catatonic syndrome after neuroleptic malignant syndrome].

Benjelloun G, Jehel L, Abgrall G, Pelissolo A, Allilaire J.

Encephale. 2005 Nov-Dec;31(6 Pt 1):705-9. French.

PMID:
16462690
11.

Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.

Luchini F, Lattanzi L, Bartolommei N, Cosentino L, Litta A, Kansky C, Mauri M, Cassano GB, Fagiolini A, Casamassima F.

J Nerv Ment Dis. 2013 Jan;201(1):36-42. doi: 10.1097/NMD.0b013e31827ab24b.

PMID:
23274293
12.

Neuroleptic malignant syndrome in Mexico.

Montoya A, Ocampo M, Torres-Ruiz A.

Can J Clin Pharmacol. 2003 Fall;10(3):111-3.

PMID:
14506509
13.

Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.

Tsai JH, Yang P, Yen JY, Chen CC, Yang MJ.

Pharmacotherapy. 2005 Aug;25(8):1156-9.

PMID:
16207109
14.

[Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison].

Schröder J, Linge C, Wähner A.

Fortschr Neurol Psychiatr. 1988 Mar;56(3):97-101. German.

PMID:
2896144
15.

Catatonic syndrome following recovery from neuroleptic malignant syndrome.

Dent J.

J Intellect Disabil Res. 1995 Oct;39 ( Pt 5):457-9.

PMID:
8555725
16.

High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome.

Hermesh H, Manor I, Shiloh R, Aizenberg D, Benjamini Y, Munitz H, Weizman A.

J Clin Psychopharmacol. 2002 Jun;22(3):252-6.

PMID:
12006894
17.

Clinical risk factors for neuroleptic malignant syndrome.

Berardi D, Dell'Atti M, Amore M, De Ronchi D, Ferrari G.

Hum Psychopharmacol. 2002 Mar;17(2):99-102.

PMID:
12404699
18.

Residual catatonic state following neuroleptic malignant syndrome.

Caroff SN, Mann SC, Keck PE Jr, Francis A.

J Clin Psychopharmacol. 2000 Apr;20(2):257-9. Review.

PMID:
10770467
19.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460
20.

[Catatonia, malignant neuroleptic syndrome and myositis ossificans].

Topka H, Buchkremer G.

Nervenarzt. 1996 May;67(5):413-7. German.

PMID:
9005354

Supplemental Content

Support Center